Oxigen Sol (Oxygen)

Oxigen Sol is used in respiratory care pathways for conditions that impair oxygenation.

• Acute hypoxemia: improves oxygen saturation and supports tissue oxygen delivery.
• Chronic obstructive pulmonary disease (COPD): helps maintain adequate oxygen levels during exacerbations.
• Post‑operative recovery: provides supplemental oxygen to aid healing and reduce hypoxic stress.
• High‑altitude exposure: prevents hypoxia‑related symptoms in susceptible individuals.
• Carbon dioxide reduction therapy (ECMO or ECCO₂ R R ): enhances oxygen transfer in extracorporeal circuits for critical care patients.

• Oxigen Sol delivers molecular oxygen directly to the alveolar space, increasing the partial pressure of oxygen in the lungs. The elevated gradient drives diffusion of oxygen across the alveolar‑capillary membrane into the bloodstream, raising arterial oxygen tension and supporting cellular respiration in tissues that are hypoxic or under increased metabolic demand.

Oxigen Sol may cause adverse reactions related to the delivery of a gas to the respiratory tract.

Common Side Effects

• Dry mouth or throat irritation.
• Cough or mild bronchospasm.
• Nasal congestion or discomfort from nasal cannula.
• Headache due to changes in CO₂ retention.
• Mild dizziness or light‑headedness.

Serious or Rare Side Effects

• Oxygen toxicity leading to pulmonary inflammation.
• Seizures from high‑concentration exposure.
• Vision changes (retinopathy) with prolonged high‑dose therapy.
• Barotrauma from excessive airway pressure.
• Severe bronchospasm or anaphylactoid reaction.
• Hypercapnia in patients with impaired CO₂ clearance.

When using Oxigen Sol, follow safety and handling guidelines to protect patients and staff.

• Patient assessment: verify indication and required oxygen flow rate before administration.
• Monitoring: continuously observe oxygen saturation and respiratory status during therapy.
• Equipment check: ensure delivery devices (cannula, mask, ventilator) are clean and functioning.
• Contraindications: avoid use in patients with untreated pneumothorax or severe hypercapnic respiratory failure unless closely monitored.
• Fire safety: keep away from open flames and sources of ignition.
• Store at ambient temperature: keep container in original packaging, protect from direct sunlight and extreme temperatures.

Oxigen Sol can interact with other therapies that affect respiratory function or oxygen metabolism.

Major Interactions (Avoid)

• Nitrogen dioxide exposure: combined use may increase risk of lung irritation.
• High‑concentration anesthetic gases: may potentiate respiratory depression.

Moderate Interactions (Monitor Closely)

• Sedatives or opioids: monitor for additive respiratory depression.
• Bronchodilators: assess response as oxygen may alter drug efficacy.
• Carbon‑monoxide poisoning treatment: adjust oxygen flow to avoid rebound hypoxia.
• Hyperbaric oxygen therapy: coordinate dosing to prevent oxygen toxicity.
• Inhaled corticosteroids: watch for increased local irritation.